Coordinate My Care (CMC), Powered by InterSystems, Announce Public Launch of myCMC
Coordinate My Care has publicly launched its new service, myCMC, powered by InterSystems HealthShare, which enables patients in London to create their own urgent care plans and share them with health professionals.
Read more ...
Siemens Healthineers Achieves Important Milestone in Quantifiable Tissue Analysis Using MR
At the ISMRM (International Society for Magnetic Resonance in Medicine) in Montreal, Canada, Siemens Healthineers is the first supplier in the world to offer magnetic resonance fingerprinting (MRF) as a product for tissue analysis in clinical neurological research.
Read more ...
Philips Announces Collaboration with Medtronic to Further Advance the Image-Guided Treatment of Atrial Fibrillation
Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures.
Read more ...
Chipmunk Health Chooses Philips HealthSuite Digital Platform to Roll Out and Scale Up its Telehealth Services
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that telehealth service provider Chipmunk Health, with locations in the Netherlands and Canada, is leveraging the capabilities and services of Philips' HealthSuite digital platform to roll out its new GP-to-patient home monitoring solutions.
Read more ...
Bayer Joins Sensyne Health Consortium Working on National Linked Patient Data Capability for Accelerating the Discovery of New Medicines
Sensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together on the development of a national linked patient data capability. Bayer joins Microsoft, EY, JP Morgan, and Peel Hunt in this consortium.
Read more ...
AstraZeneca Starts Artificial Intelligence Collaboration to Accelerate Drug Discovery
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF).
Read more ...
Red Hat Helps Public Health England Use Open Source to Pursue Hybrid Cloud Operations
Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, announced that Public Health England (PHE), an executive agency of the Department of Health and Social Care in the United Kingdom, is using Red Hat's open hybrid cloud technologies to support modern digital public health services in the UK.
Read more ...